X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6409) 6409
Book Review (2125) 2125
Publication (662) 662
Book Chapter (48) 48
Conference Proceeding (18) 18
Reference (6) 6
Dissertation (4) 4
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5241) 5241
glucagon-like peptide-1 (4322) 4322
humans (3641) 3641
animals (2923) 2923
endocrinology & metabolism (2281) 2281
male (2003) 2003
type 2 diabetes (1707) 1707
diabetes (1684) 1684
diabetes mellitus, type 2 - drug therapy (1635) 1635
glucose (1319) 1319
glucagon (1279) 1279
hypoglycemic agents - therapeutic use (1244) 1244
glucagon-like peptide-1 receptor (1235) 1235
insulin (1221) 1221
mice (1151) 1151
pharmacology & pharmacy (1136) 1136
female (1082) 1082
glp-1 (1050) 1050
rats (1027) 1027
peptides (997) 997
liraglutide (957) 957
obesity (888) 888
glycemic control (851) 851
exenatide (759) 759
glucagon-like peptide 1 (714) 714
diabetes mellitus (711) 711
middle aged (692) 692
hypoglycemic agents - pharmacology (679) 679
peptides - pharmacology (679) 679
receptors, glucagon - agonists (677) 677
analysis (636) 636
insulin - metabolism (625) 625
blood glucose - metabolism (620) 620
physiological aspects (620) 620
glucagon-like peptide-1 receptor - agonists (607) 607
research (593) 593
glucagon-like peptide 1 - metabolism (589) 589
exendin-4 (576) 576
dextrose (570) 570
biochemistry & molecular biology (569) 569
type-2 diabetes-mellitus (556) 556
rodents (547) 547
abridged index medicus (546) 546
venoms - pharmacology (545) 545
internal medicine (532) 532
diabetes mellitus, type 2 - metabolism (529) 529
physiology (512) 512
adult (511) 511
care and treatment (504) 504
insulin secretion (499) 499
receptors, glucagon - metabolism (490) 490
secretion (490) 490
health aspects (488) 488
double-blind (487) 487
insulin resistance (482) 482
glucagon-like peptide 1 - analogs & derivatives (481) 481
diabetes mellitus, type 2 - blood (479) 479
endocrine system (476) 476
hypoglycemic agents - administration & dosage (475) 475
treatment outcome (469) 469
aged (467) 467
medicine & public health (466) 466
hypoglycemic agents (462) 462
beta-cell function (447) 447
hypoglycemic agents - adverse effects (445) 445
peptides - therapeutic use (445) 445
metformin (444) 444
blood glucose - drug effects (443) 443
food-intake (443) 443
digestive, oral, and skin physiology (442) 442
risk factors (440) 440
insulin-secretion (430) 430
drug therapy (426) 426
glucagon-like peptide 1 - pharmacology (423) 423
dipeptidyl-peptidase iv inhibitors - therapeutic use (419) 419
expression (415) 415
mice, inbred c57bl (415) 415
diabetes therapy (413) 413
hyperglycemia (406) 406
metabolism (399) 399
neurosciences (399) 399
hormones, hormone substitutes, and hormone antagonists (391) 391
receptor (386) 386
glucagon-like peptide 1 - therapeutic use (384) 384
article (380) 380
medicine, research & experimental (379) 379
glucose metabolism (375) 375
body weight (372) 372
incretin (365) 365
rats, sprague-dawley (365) 365
glucagon-like peptide-1 receptor - metabolism (354) 354
type 2 diabetes mellitus (346) 346
venoms - therapeutic use (339) 339
signal transduction (335) 335
gastric-inhibitory polypeptide (334) 334
glucose - metabolism (334) 334
insulin-secreting cells - metabolism (332) 332
review (332) 332
cell biology (325) 325
dependent insulinotropic polypeptide (324) 324
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6281) 6281
German (44) 44
Spanish (30) 30
Japanese (19) 19
French (12) 12
Korean (10) 10
Chinese (9) 9
Italian (8) 8
Czech (3) 3
Russian (3) 3
Danish (2) 2
Hungarian (2) 2
Polish (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, ISSN 0012-1797, 01/2016, Volume 65, Issue 1, pp. 172 - 187
Retinal neurodegeneration is an early event in the pathogenesis of diabetic retinopathy (DR). Since glucagon-like peptide 1 (GLP-1) exerts neuroprotective... 
INSULIN | ALZHEIMER-DISEASE | APOPTOSIS | CELLS | EXENDIN-4 ANALOG | EARLY EVENT | ENDOCRINOLOGY & METABOLISM | RETINOPATHY | UP-REGULATION | EXPRESSION | PROTECTS | Immunohistochemistry | Retina - drug effects | Administration, Ophthalmic | Glucagon-Like Peptide 1 | Apoptosis - drug effects | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - metabolism | Glial Fibrillary Acidic Protein - metabolism | Glucagon-Like Peptide-1 Receptor - genetics | Glucagon-Like Peptide-1 Receptor - metabolism | Neuroprotective Agents - pharmacology | Liraglutide - pharmacology | Female | Diabetes Mellitus, Experimental - complications | Diabetic Retinopathy - etiology | Retinal Neurons - drug effects | Diabetes Mellitus, Experimental - metabolism | Real-Time Polymerase Chain Reaction | Diabetes Mellitus, Type 2 - complications | Electroretinography | Blotting, Western | Peptides - pharmacology | Diabetic Retinopathy - prevention & control | Animals | Glial Fibrillary Acidic Protein - drug effects | Aged | Mice | Retinal Neurons - pathology | Venoms - pharmacology | Retina - pathology | Glucagon-Like Peptide-1 Receptor - agonists | Diabetic retinopathy | Care and treatment | Glucagon | Dosage and administration | Research | Gene expression | Insulin | Neuropeptides | Retina | Diabetes | Neurodegeneration | Index Medicus | Abridged Index Medicus
Journal Article
Endocrinology, ISSN 0013-7227, 04/2010, Volume 151, Issue 4, pp. 1473 - 1486
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 10/2014, Volume 124, Issue 10, pp. 4473 - 4488
Journal Article
Journal Article
by Wang, B and Zhong, J and Lin, H and Zhao, Z and Yan, Z and He, H and Ni, Y and Liu, D and Zhu, Z
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2013, Volume 15, Issue 8, pp. 737 - 749
Aims: Aside from lowering blood glucose, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) attract much attention because of their cardioprotective... 
randomized trials | GLP | meta‐analysis | hypertension | Hypertension | GLP-1 | Randomized trials | Meta-analysis | GLYCEMIC CONTROL | meta-analysis | WEIGHT-LOSS | ANALOG LIRAGLUTIDE | OPEN-LABEL | TWICE-DAILY EXENATIDE | DRUG-NAIVE PATIENTS | GLUCAGON-LIKE PEPTIDE-1 | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | TYPE-2 DIABETES-MELLITUS | CARDIOVASCULAR RISK-FACTORS | Cardiovascular Diseases - prevention & control | Humans | Hypertension - drug therapy | Male | Hypertension - blood | Cardiovascular Diseases - blood | Female | Blood Pressure - drug effects | Diabetic Angiopathies - prevention & control | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Glucagon-Like Peptide 1 - analogs & derivatives | Sulfonylurea Compounds - therapeutic use | Treatment Outcome | Diabetic Angiopathies - blood | Randomized Controlled Trials as Topic | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Glucagon-Like Peptide-1 Receptor | Venoms - therapeutic use | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Liraglutide | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Glucose metabolism | Peptides | Blood sugar | Blood pressure | Hypoglycemic agents | Confidence intervals | Medical research | Drug therapy | Index Medicus
Journal Article
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 09/2017, Volume 19, Issue 9, pp. 1233 - 1241
Journal Article
Diabetes Care, ISSN 0149-5992, 01/2011, Volume 34, Issue 1, pp. 90 - 95
Journal Article